We are live on ! Find out more
RLYB icon

Rallybio

53 hedge funds and large institutions have $183M invested in Rallybio in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 14

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

0.36% less ownership

Funds ownership: 10.91%10.54% (-0.36%)

7% less funds holding

Funds holding: 5753 (-4)

14% less capital invested

Capital invested by funds: $212M → $183M (-$28.7M)

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

Holders
53
Holders Change
-4
Holders Change %
-7.02%
% of All Funds
0.84%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
3
Increased
19
Reduced
14
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AIP
51
Ameritas Investment Partners
Nebraska
$8.05K
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
$6K -$11.4K -220 -63%
Walleye Capital
53
Walleye Capital
New York
-$526K -10,012 Closed
Renaissance Technologies
54
Renaissance Technologies
New York
-$91K -1,725 Closed
Squarepoint
55
Squarepoint
New York
-$86.5K -1,646 Closed
MIM
56
MetLife Investment Management
New Jersey
-$67.5K -1,285 Closed
MLICM
57
Metropolitan Life Insurance Company (MetLife)
New York
-$8.66K -165 Closed
Allspring Global Investments
58
Allspring Global Investments
North Carolina
-$6.61K -126 Closed
Citigroup
59
Citigroup
New York
-$4.27K -81 Closed
CS
60
Credit Suisse
Switzerland
-$7

RLYB Hedge Fund Activity: Q1 2023 in Review

53 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Rallybio (RLYB) for Q1 2023, worth a combined $183M — down 14% from $212M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of RLYB and 3 opened new positions — a net loss of 4 holders — while 14 trimmed existing stakes and 19 added.

The largest buyer was Geode Capital Management, adding an estimated $418K. The largest seller was 5AM Venture Management, cutting an estimated $646K.

  • 53 institutional investors held Rallybio (RLYB) as of Q1 2023, down from 57 in Q4 2022.
  • Funds reported $183M of Rallybio stock for Q1 2023, down 14% quarter-over-quarter.
  • 3 funds opened new Rallybio positions in Q1 2023 and 7 closed out, a net change of -4 holders.
  • The largest Rallybio buyer in Q1 2023 was Geode Capital Management, an estimated $418K added.
  • The largest Rallybio seller in Q1 2023 was 5AM Venture Management, an estimated $646K sold.

Based on aggregated 13F filings for Q1 2023.